| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/09/2004 | US20040176582 Expression vector comprising osteocalcin promoter and nucleotide sequence coding bone morphogenic protein for treatment and prevention of osteoporosis |
| 09/09/2004 | US20040176572 Nucleotide sequences coding nervous system polypeptide for use in diagnosis, prevention and treatment of neurodegenerative and psychological disorders |
| 09/09/2004 | US20040176571 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/09/2004 | US20040176570 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 09/09/2004 | US20040176568 Nucleic acids encoding modified parathyroid hormone |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176329 Treating Alzheimer*s, Parkinson*s, and Binswanger*s disease; antiischemic agents, dementia; nervous system, brain and neurodegenerative disorders |
| 09/09/2004 | US20040176319 Cellular uptake of bioactive agents |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040175827 used to treat graft-versus-host-disease, tumors, and autoimmune disorders; solid phase synthesis |
| 09/09/2004 | US20040175826 for isolating chondrocytes from mandibular condyle tissue and being depleted of fibroblast-like cells and/or myocytes; enzyme inhibitors |
| 09/09/2004 | US20040175825 for drug screening/diagnostics for inflammation, arthritis and cancer; genetic engineering; kits |
| 09/09/2004 | US20040175823 Isolation of spore-like cells from tissues exposed to extreme conditions |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175791 DcR3 polypeptide, a TNFR homolog |
| 09/09/2004 | US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering |
| 09/09/2004 | US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction |
| 09/09/2004 | US20040175786 for the prevention of acute rejection reactions following organ transplantation; genetic engineering |
| 09/09/2004 | US20040175773 Screening method based on siah-numb interaction |
| 09/09/2004 | US20040175766 Human pyrimidine receptor |
| 09/09/2004 | US20040175755 Using apolipoprotein specific immunoglobulin to diagnosis and treat arteriosclerosis, hyperlipidemia and cardiovascular disorders |
| 09/09/2004 | US20040175748 Using alterations in cyclin dependent kinase activity to identify modulators which inhibit or potentiate cellular senescence; antiaging/anticancer agents; enzyme inhibitors |
| 09/09/2004 | US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome |
| 09/09/2004 | US20040175692 Chronic lymphocytic leukemia cell line |
| 09/09/2004 | US20040175393 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and imunological therapies based thereon |
| 09/09/2004 | US20040175377 Agent and method for reducing intraocular pressure |
| 09/09/2004 | US20040175373 Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 09/09/2004 | US20040175369 Stat3 antagonists and their use as vaccines against cancer |
| 09/09/2004 | US20040175367 Culture comprising artificial stroma comprising mixture of collagen, human fibroblasts from colon or intestine; overlayed with epithelial cells; and growth factor that binds receptors of insulin growth factor, epidermal growth factor, and/or leukemia inhibitory factor; drug screening, wound healing |
| 09/09/2004 | US20040175366 Comprising devitalized mammalian parenchymatous tissue combined with target mammalian cell population sized and shaped for implantation at anatomical site in patient remote from tissue requiring regeneration; |
| 09/09/2004 | US20040175364 Gene transfer with adenoviruses having modified fiber proteins |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175357 IL-2 selective agonists and antagonists |
| 09/09/2004 | US20040175354 in particular cells and cellular components in solution to surfaces, characterized in that to the solution is added at least one polyalcohol |
| 09/09/2004 | US20040173778 homogeneous clonal populations derived therefrom with enhanced suppressive activity and their uses in the regulation of immune responses and for the identification and characterization of suppressor T cell specific molecules |
| 09/08/2004 | EP1454629A2 Insulinotrophic agent based on preproglucagon |
| 09/08/2004 | EP1454600A1 Ectocornea-like sheet and method of constructing the same |
| 09/08/2004 | EP1453968A2 Bgl4 beta-glucosidase and nucleic acids encoding the same |
| 09/08/2004 | EP1453967A2 Bgl5 beta-glucosidase and nucleic acids encoding the same |
| 09/08/2004 | EP1453966A1 Method for producing a recombinant polypeptide |
| 09/08/2004 | EP1453963A2 A structure for presenting desired peptide sequences |
| 09/08/2004 | EP1453960A1 Dna construct for assessing thymic function activity and therapeutical uses thereof |
| 09/08/2004 | EP1453957A2 Method of large scale production of hepatitis a virus |
| 09/08/2004 | EP1453956A1 Method for large scale production of virus antigen |
| 09/08/2004 | EP1453955A2 Cell constructs cultured in vitro, preparation and uses |
| 09/08/2004 | EP1453954A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 09/08/2004 | EP1453953A1 Method for producing stem cells with increased developmental potential |
| 09/08/2004 | EP1453952A2 Compositions and methods for normalizing assays |
| 09/08/2004 | EP1453951A2 Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453948A2 Cell culture process |
| 09/08/2004 | EP1453947A1 Device for active phase cell or tissue sampling and uses thereof |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453850A2 Egviii endoglucanase and nucleic acids encoding the same |
| 09/08/2004 | EP1453840A1 Phosphonates useful as modulators of t-gamma-9-delta-2 lymphocyte activity |
| 09/08/2004 | EP1453556A1 Method for forming matrices of hardened material |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453383A2 A novel saitohin gene and uses of same |
| 09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
| 09/08/2004 | EP1397503A4 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore |
| 09/08/2004 | EP1294867B1 Human site-1 protease promoter |
| 09/08/2004 | EP1180134B1 Multi- applicable cell-culture method and apparatus |
| 09/08/2004 | EP1131087B1 Methods of alleviating cancer symptoms |
| 09/08/2004 | EP1087995B1 A method for inducing production of growth factors |
| 09/08/2004 | EP1073420A4 Specially devised neuronal implants for reconstruction of damaged central nervous system |
| 09/08/2004 | EP1056334B1 A method for the production of transgenic plants using apical shoot tips |
| 09/08/2004 | EP1017802B1 A potential effector for the grb7 family of signalling proteins |
| 09/08/2004 | EP0991426B1 Method for transferring nucleic acid into the striated muscle |
| 09/08/2004 | EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | EP0873405B1 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
| 09/08/2004 | CN1527927A Cryopreservation system with controlled dendritic freezing front velocity |
| 09/08/2004 | CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor |
| 09/08/2004 | CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 09/08/2004 | CN1527697A Immune modulation device for use in animals |
| 09/08/2004 | CN1526822A Method of raising antibacterial and antiviral property of plant |
| 09/08/2004 | CN1526821A New glucoamylase and coding its nucleic acid sequence |
| 09/08/2004 | CN1526820A Promotor for expressing gene in fungal cell |
| 09/08/2004 | CN1526817A Anhydrant gene BcDh1 and the application of its promoter in raising drought-enduring plant |
| 09/08/2004 | CN1526814A Human Tumor cell separating and purifying process |
| 09/08/2004 | CN1165615C Subtilase variants and compositions |
| 09/08/2004 | CN1165214C Method for producing virus-free rootstocks of hop |
| 09/07/2004 | US6787647 Carnitine carrier related protein-1 |
| 09/07/2004 | US6787644 Metalloprotease-disintegrin ADAM23 (SVPH3-17) nucleic acids |
| 09/07/2004 | US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection |
| 09/07/2004 | US6787641 Identification of sel-12 and uses thereof |
| 09/07/2004 | US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn. |
| 09/07/2004 | US6787519 Methods of treating disorders related to apoE |
| 09/07/2004 | US6787358 By culturing cells on a prepatterned surface and transferring to a second surface; matrix proteins; thrombin; for bioelectrical devices, sensors, electrical components, tissues, implants and transplants |
| 09/07/2004 | US6787357 Plasma-derived fibrin-based matrices and tissue |
| 09/07/2004 | US6787356 Cell expansion system for use in neural transplantation |
| 09/07/2004 | US6787355 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 09/07/2004 | US6787353 Self-renewing restricted stem cells for treating neurological diseases; can differentiate into multiple neuronal but not glial phenotypes |
| 09/07/2004 | US6787351 Composition for the prevention of preferential viral infections |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787327 Encoded by isolated nucleic acid; high throughput enzymatic assay; screening for modulators of enzymatic activity |
| 09/07/2004 | US6787326 For destruction in normoxic but not hypoxic cells; promotes angiogenesis and/or cellular survival; fusion proteins |
| 09/07/2004 | US6787323 Monitoring vascular endothelial growth factor activity in a sample; obtain sample, incubate with preferential genetically engineered cells, detecting expression of the reporter element, expression indicates growth factor activity |